Brought to you by 
Alexza Pharmaceuticals nets $20.7mm in follow-on offering
22 Feb 2012
Executive Summary
In a follow-on public offering, Alexza Pharmaceuticals Inc. (inhaled CNS drug delivery) netted $20.7mm by selling 44mm shares at $0.50. Investors also received five-year warrants to buy 44mm shares at $0.50.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alexza Pharmaceuticals nets $20.7mm in follow-on offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice